| In
Germany more than 400.000 individuals per year are newly diagnosed with
malignant disease. Among these almost 5.000 cases belong to the group of head
and neck cancer. Due to improved diagnostic tools and a higher live expectancy
there is a tedency towards an continuously increasing prevalence for malignant
diseases. This development leads to a growing demand for dental care in
individuals that have already completed or are currently undergoing oncologic
tretament. The following contribution provides information on the impact of
oncologic disease and its treatment on dental care. |
|
